Küttner's tumor belongs to the fields of autoimmune and rheumatic immunity. The clinical manifestations are complex and often involve multi-systematic strain. Early identification and normalisation of the disease are essential for improving prognosis.
The diagnosis of the disease requires a combination of clinical manifestations, imaging inspections, laboratory tests and pathological activation. The platform can assist in matching authoritative experts and teams at home and abroad to provide accurate diagnosis and treatment plans. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many autoimmune and rheumatic immune diseases that were previously difficult to treat have been significantly improved.
Treatment requires close monitoring of therapeutic effects and adverse reactions, adapting to timely regimens according to changes in the condition. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of Küttner's tumor. The platform serves China's international medical service system, a team of nationally authorized experts in the field of autoimmune and rheumatic immunity, to provide the following services to patients: Remote pre-diagnosis: by the team of experts reviewing the medical history, clear diagnostic directions and medical advice on: 1.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.